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ABSTRACT  23 
Sapelovirus A (SV-A), formerly known as Porcine Sapelovirus as a member of a new 24 
genus Sapelovirus, is known to cause enteritis, pneumonia, polioencephalomyelitis, 25 
and reproductive disorders in pigs. We have recently identified α2,3-linked sialic acid 26 
on GD1a ganglioside as a functional SV-A receptor rich in the cells of pigs and 27 
chickens. However, the role of GD1a in viral pathogenesis remains elusive. Here, we 28 
demonstrated that a Korean SV-A strain could induce diarrhea and intestinal 29 
pathology in piglets but not in chicks. Moreover, this Korean SV-A strain had mild 30 
extra-intestinal tropisms appeared as mild non-suppurative myelitis, encephalitis and 31 
pneumonia in piglets, but not in chicks. By real-time RT-PCR, higher viral RNA levels 32 
were detected in fecal samples than in sera or extra-intestinal organs from virus-33 
inoculated piglets. Immunohistochemistry confirmed that high viral antigens were 34 
detected only in the epithelial cells of intestines from virus-inoculated piglets but not 35 
from chicks. This Korean SV-A strain could bind the cultured cell lines originated 36 
from various species but replication occurred only in cells of porcine origin. These 37 
data indicated that this Korean SV-A strain could replicate and induce pathology in 38 
piglets but not in chicks, suggesting that additional porcine specific factors are 39 
required for virus entry and replication. In addition, this Korean SV-A strain is 40 
enteropathogenic but could spread to the bloodstream from the gut and disseminate 41 
to extra-intestinal organs and tissues. These results will contribute to our 42 
understanding of SV-A pathogenesis so that efficient anti-sapelovirus drugs and 43 
vaccines could be developed in the future. 44 
 45 
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INTRODUCTION 47 
The Picornaviridae family, comprising 29 genera, consists of a diverse family of 48 
non-enveloped viruses with positive sense single-stranded RNA genomes 49 
(Racaniello, 2013; http://talk.ictvonline.org/files/master-species-lists/m/msl/5208). 50 
Viruses in this family can cause a wide range of diseases, including intestinal, 51 
respiratory, neurological, cardiac, hepatic, mucocutaneous and systemic diseases of 52 
various severities in both humans and animals (Racaniello, 2013). Since porcine 53 
enterovirus 8 (PEV-8), simian type 2 picornavirues, and duck picornavirus TW90A 54 
have a unique genomic organization different from other picornavirus genera (Son et 55 
al., 2014a), the genus Sapelovirus is a newly assigned member of the Picornaviridae 56 
family (Adams et al., 2015). The Sapelovirus genus consists of three species: 57 
Sapelovirus A (SV-A) formerly known as porcine sapelovirus, Sapelovirus B formerly 58 
named as simian sapelovirus, and Avian Sapelovirus formerly known as duck 59 
picornavirus TW90A (Adams et al., 2015).  60 
SV-A can cause asymptomatic and symptomatic diseases in both field and 61 
experimental pigs (Alexandersen et al., 2012; Kim et al., 2016). The symptomatic 62 
disorders include diarrhea, pneumonia, polioencephalomyelitis and reproductive 63 
disorders (Alexandersen et al., 2012; Huang et al., 1980; Lamont & Betts, 1960; Lan 64 
et al., 2011; Schock et al., 2014; Sibalin, 1963). Experimental studies have 65 
demonstrated a diverse range of clinical symptoms (Lamont & Betts, 1960; Lan et al., 66 
2011; Sibalin, 1963; Yamanouchi et al., 1965). These differences largely depend on 67 
age, route of infection, and strains inoculated (Alexander & Betts, 1967; Lamont & 68 
Betts, 1960; Lan et al., 2011; Sibalin, 1963; Yamanouchi et al., 1965).  69 
Significant antigenic diversity has been observed in SV-As isolated from 70 
different countries and continents (Bohl et al., 1960; Dunne et al., 1967,1971; Izawa 71 
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et al., 1962; Kadoi et al., 1970; L’Ecuyer & Greig, 1966). The genomes of SV-As and 72 
other members in the genus Sapelovirus have the typical picornavirus genome 73 
organization: 5’ untranslated region (UTR)-L-VP4-VP2-VP3-VP1-2A-2B-2C-3A-3B-74 
3C-3D-3’ UTR (Tseng & Tsai, 2007; Krumbholz et al., 2002; Oberste et al., 75 
2002,2003; Son et al., 2014a). However, there are significant structural differences in 76 
the SV-A genome, e.g, the cis-acting RNA element (CRE) in the 2c coding region 77 
and kissing domain in the 3’UTR are vary between recent Korean and Chinese 78 
strains and older English and Chinese strains (Son et al., 2014a). These differences 79 
in antigenic diversity and structural features could influence the pathogenicity and/or 80 
host range restriction of SV-A strains yet we have a limited understanding of the 81 
pathogenesis of SV-A (Son et al., 2014a). 82 
In comparison to other picornaviruses, the SV-A life cycle remains poorly 83 
characterized. We have recently demonstrated that SV-A can recognize α2,3-linked 84 
sialic acid (SA) on GD1a as a functional SV-A receptor (Kim et al., 2016). Alph2,3-85 
linked SA is known to be highly expressed on cells of porcine and avian origin (de 86 
Graaf & Fouchier, 2014; Raman et al., 2014), indicating that SV-A has the potential 87 
to be able to infect both pigs and chickens. Therefore, the objective of this study was 88 
to undertake a comparative analysis of the pathogenesis of a Korean SV-A strain in 89 
piglets and chicks.  90 
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RESULTS 91 
The SV-A strain caused diarrhea and fecal viral shedding in piglets but not in 92 
chicks 93 
Chicken cells are typically rich in α2,3-linked SA, whereas porcine cells are abundant 94 
in both α2,3- and α2,6-linked SAs (Raman et al., 2014). Our previous results have 95 
demonstrated that SV-A could recognize α2,3-linked SA as a receptor (Kim et al., 96 
2016), suggesting that SV-A might be able to infect and induce pathology in both 97 
pigs and chicks. To determine whether SV-A could induce diarrhea and fecal viral 98 
shedding in piglets and chicks, 3-day-old piglets obtained from sows by 99 
hysterectomy and 3-day-old specific pathogen free (SPF) chicks were orally 100 
inoculated with 2 x 109 PFU/ml or 5 x 108 PFU/ml of SV-A (KS04105 strain), 101 
respectively. Compared to mock-inoculation, piglets inoculated with SV-A strain had 102 
continuous diarrhea from 1 day post-inoculation (dpi) to 5 dpi (data not shown). 103 
However, diarrhea was not observed in mock- or SV-A-inoculated chicks during the 104 
entire experimental period.  105 
To assess fecal viral shedding, one-step real-time quantitative reverse transcription-106 
polymerase chain reaction (qRT-PCR) assay was performed with fecal samples 107 
sequentially collected from mock- or SV-A-inoculated piglets and chicks (Chen et al., 108 
2014). High viral RNA levels were detected in fecal samples collected from piglets at 109 
1 dpi, reaching a peak at 3 dpi followed by decreasing viral loads from 5 dpi (Fig. 1a). 110 
However, SV-A RNA was only detected at 1 dpi from feces of SV-A-inoculated chicks 111 
(Fig. 1b), most likely representing virus inoculum passing through the intestines. 112 
Collectively, these data indicated that SV-A could induce diarrhea and fecal shedding 113 
in piglets but not in chicks.  114 
 115 
6 
 
The SV-A strain caused intestinal and extra-intestinal lesions in piglets but not 116 
in chicks 117 
We then assessed the histopathological changes in organs and tissues sequentially 118 
sampled from mock- or SV-A-inoculated piglets and chicks. SV-A infection resulted in 119 
histopathological changes in the small intestines of virus-inoculated piglets, including 120 
villous atrophy and crypt hyperplasia at 1 dpi (Table 1). These mucosal changes 121 
were gradually increased in all regions of the small intestine until 5 dpi followed by a 122 
decrease at 7 dpi (Fig. 2 and Table 1). Large intestinal lesions including crypt fusion 123 
with epithelial cell hyperplasia was observed at 2 dpi, increased until 5 dpi followed 124 
by a decrease at 7 dpi (Fig. 2). Lungs from infected piglets showed lymphoid cell 125 
infiltration in the peribronchiolar submucosa and perivascular space from 5 dpi to the 126 
end of the experiment (Fig. 3). As shown in Table 2, adaptive immune reactions to 127 
SV-A infection evident as perivascular cuffing of lymphocytes and gliosis were 128 
observed in both gray and white matters of spinal cord (myelitis) and brain 129 
(encephalitis) (Fig. 3). These typical host defence reactions were observed from 7 130 
dpi until the termination of the experiment. Neuronophagia and chromatolysis were 131 
not frequently found in the spinal cord or the brain. However, spinal cords showed 132 
stronger inflammatory reactions than the brain (Table 2). No specific lesion was 133 
observed in other organs or tissues collected from piglets regardless of SV-A 134 
infection. However, SV-A did not induce any histopathological change in any organ or 135 
tissue sequentially sampled from SV-A-inoculated chicks during the entire 136 
experimental period (Fig. 4). These data indicated that SV-A could induce pathology 137 
in piglets but not in chicks. 138 
 139 
Viral antigen was detected only in the intestine of piglets but not chicks 140 
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To assess the distributions of SV-A antigen in the organs and tissues, 141 
immunohistochemical assay was performed with organs and tissues sampled 142 
sequentially from mock- or SV-A-infected piglets and chicks using monoclonal 143 
antibody (Mab) specific to SV-A capsid protein. SV-A antigen was only detected in 144 
the epithelial cells of villi from SV-A infected piglets at 1 dpi to 5 dpi (Fig. 2 and Table 145 
1). Other organs and tissues collected from mock- or SV-A-inoculated piglets were 146 
negative for SV-A antigen (Fig. 3 and Table 2). Consistent with clinical and 147 
histopathological observations, SV-A antigen was not detected in any organ or tissue 148 
collected from SV-A-inoculated chicks (Fig. 4). 149 
 150 
The SV-A caused viremia and replicated in extra-intestinal organs of piglets 151 
but not chicks 152 
To assess whether SV-A induced viremia and replicated in extra-intestinal organs of 153 
piglets and chicks, qRT-PCR assay was performed with sera and extra-intestinal 154 
organs and tissues collected from mock- or SV-A-inoculated piglets and chicks. SV-A 155 
RNA levels were relatively low in the sera, spinal cord, lung, and brain in comparison 156 
with those in the fecal samples collected from SV-A-inoculated piglets (Fig. 1a). 157 
However, SV-A RNA was not detected in the sera and any extra-intestinal organs 158 
and tissues collected from mock- or SV-A-inoculated chicks. These data indicated 159 
that SV-A induced viremia which was then disseminated to extra-intestinal organs 160 
and tissues in piglets but not chicks.  161 
 162 
Binding and infection abilities of SV-A to various cells 163 
To determine whether SV-A had a strict tropism for porcine cells in vitro, the binding 164 
and infection ability of SV-A was examined with various cell lines, including porcine, 165 
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human, chicken embryo, canine, simian, hamster and feline. Alexa fluor 594 166 
(AF594)-labelled SV-A attached to all cell lines at various degrees (Fig. 5a). Radio-167 
labelled SV-A was able to bind to all cells examined at similar degrees (Fig. 5b). 168 
However, SV-A was only replicated in cells of porcine origin (LLC-PK and PK-15) 169 
(Fig. 5c) with similar levels of cytopathic effect (data not shown). The SV-A genome 170 
copy numbers robustly increased in cells of porcine origin in time dependent manner 171 
but not in cells of other species (Fig. 5d). Our results indicated that only porcine cells 172 
were permissible for SV-A infection.   173 
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DISCUSSION 174 
All viruses initiate infection by binding to specific receptor(s) on the surface of 175 
susceptible host cells (Neu et al., 2011). We have previously demonstrated that SV-A 176 
could utilize α2,3-linked SA on GD1a glycolipid as a receptor (Kim et al., 2016). 177 
Indeed, glycolipid associated α2,3-terminal SA is abundant on the cell surface of 178 
both avian and porcine species (de Graaf & Fouchier, 2014; Raman et al., 2014). 179 
However, our results in this study revealed that SV-A infection was limited to cells of 180 
porcine origin. It could not infect cells of other origins including chickens and humans. 181 
Moreover, SV-A was replicated in piglets but not chicks, confirming that SV-A could 182 
not cause interspecies transmission at least between pigs and chickens. Our results 183 
also suggested that other factors in addition to glycolipid associated α2,3-terminal SA 184 
might be required for efficient SV-A replication in cells of non-porcine origin. We have 185 
previously observed that chymotrypsin or trypsin treatment to cells has no effect on 186 
virus infection (Kim et al., 2016), suggesting that cell surface associated proteins do 187 
not play accessory roles in SV-A infection. The nature of post-binding block to 188 
infection in cells from non-porcine origin is as yet unknown but it is possible the SV-A 189 
infection of avian cells induces the innate response leading to the restriction of viral 190 
replication. 191 
Although previous studies have indicated that SV-A can cause enteritis, 192 
pneumonia, polioencephalomyelitis and reproductive disorders (Alexandersen et al., 193 
2012; Huang et al., 1980; Lamont & Betts, 1960; Lan et al., 2011; Schock et al., 2014; 194 
Sibalin, 1963), the pathogenicity and/or host range restriction of SV-A have been 195 
poorly characterized. In the current study, the most significant lesions were found in 196 
the intestines during the early infection period, where severe villous atrophy was 197 
found to be associated with high viral RNA loads in the fecal samples and strong SV-198 
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A-antigen reactivity in the intestinal epithelial cells. In contrast, the spinal cord and 199 
brain mainly showed signs of adaptive immune response (non suppurative 200 
inflammation) and comparatively low viral RNA copy numbers without clear evidence 201 
of SV-A-antigen positive cells. These data indicated that the Korean SV-A strain 202 
(KS04105) used in this study was enteropathogenic. Opposite to our data, a recent 203 
study has reported that neuroinvasive English SV-A strain’s replication in the spinal 204 
cord could lead to severe adaptive immune responses (non suppurative 205 
polioencephalomyelitis) without causing lesions in other tissues (Schock et al., 2014). 206 
This English SV-A strain (G5) is phylogenetically closer to English V13 strain than to 207 
other SV-A strains circulating recently in Korea and China (Son et al., 2014a; Schock 208 
et al., 2014). The molecular basis involved in the differences in virulence and tropism 209 
among SV-A strains remains unknown. However, there is clear evidence showing 210 
that variation in RNA structures can contribute to viral virulence (Son et al., 2014a). 211 
An additional explanation for discordance in tropism may be due to different age of 212 
animals used in studies. The English SV-A study used grower pigs (Schock et al., 213 
2014), whereas this study used neonatal piglets. Further studies are required to 214 
examine the predilections of age and inoculation routes as well as antigenic and 215 
genomic differences so that our understanding on variations in SV-A pathogenesis 216 
and/or host range restriction can be improved.  217 
Similar to other enteric viruses (Blutt & Conner, 2007; Park et al., 2007), SV-A 218 
RNA loads were detected in the sera of piglets orally inoculated with SV-A strain in 219 
this study, suggesting that SV-A might be able to penetrate the gut barrier from the 220 
lumenal side through destruction of enterocytes in the villi. This result also implied 221 
that SV-A could reach other organs and tissues via cell free transmission. However, 222 
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the mechanism by which SV-A reaches the blood and spreads to other organs and 223 
tissues remains to be determined. 224 
In conclusion, this study demonstrated that the Korean SV-A strain could be 225 
replicated and induced pathology in piglets but not chicks. Our data also indicated 226 
that this Korean SV-A strain could reach the bloodstream from the gut, and be 227 
disseminated to extra-intestinal organs and tissues. These results will improve our 228 
understanding on life cycle and pathogenesis of sapeovirus so that affordable, useful, 229 
and efficient drugs could be developed for anti- sapelovirus therapy.   230 
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METHODS 231 
Cells and viruses. LLC-PK, PK-15, and human cervical cancer HeLa cells 232 
[American Type Culture Collection (ATCC)] were maintained in Eagle’s medium 233 
(EMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 234 
100 μg/ml streptomycin. Chinese hamster ovary (CHO) cells were kindly provided by 235 
Dr. Sun-Young Im, Chonnam National University, South Korea. Crandall-Reese 236 
feline kidney (CRFK), Madin-Darby canine kidney (MDCK), African green monkey 237 
kidney Vero and MA-104, human embryonic kidney 293T (HEK293T), and human 238 
lung adenocarcinoma cell line A549 cells (ATCC) were grown in Dulbecco’s modified 239 
Eagle’s medium (DMEM) supplemented with 5% FBS, 100 U/ml penicillin, and 100 240 
μg/ml streptomycin. MA-104 cells (ATCC) were cultured in alpha minimum essential 241 
medium supplemented with 5% FBS, 100 U/ml penicillin, and 100 μg/ml 242 
streptomycin. Human lung fibroblast WI-38 cells (ATCC) were maintained in DMEM 243 
supplemented with 5% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. 244 
Primary chicken embryo cells [including primary chicken embryo fibroblast (CEF), 245 
kidney (CEK), and intestine (CEI) cells from 12-day-old specific pathogen free (SPF) 246 
White Leghorn fetus] were grown in M199 medium supplemented with 10% FBS, 247 
100 U/ml penicillin, and 100 μg/ml streptomycin.  248 
SV-A strain KS04105 used in this study were isolated from fecal samples of 249 
diarrheic piglets of South Korea (Son et al., 2014a,b). This strain was passaged eight 250 
times in LLC-PK cells, including isolation, adaptation, and triple plaque purification. 251 
Isolated viruses were confirmed as PSVs based on immunofluorescence assay (IFA), 252 
reverse transcription-polymerase chain reaction and transmission electron 253 
microscopy (Kim et al., 2016; Son et al., 2014a,b).  254 
 255 
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Reagents and antibodies. AF-594 succinimidyl ester purchased from Molecular 256 
Probes (catalog number, A-20004) was dissolved in dimethyl sulfoxide (DMSO). The 257 
Mab against SV-A capsid protein was kindly provided by Dr. M. Dauber (Friedrich-258 
Loeffler Institute, Germany). Fluorescein isothiocynate-conjugated goat anti-mouse 259 
IgG antibody and peroxidase-conjugated goat anti-mouse IgG antibody were 260 
purchased from Santa Cruz Biotechnology. Horseradish peroxidase-conjugated 261 
streptavidin was obtained from Jackson Immuno Research Lab. SlowFade Gold 262 
Antifade Reagent (Invitrogen) containing 4',6-diamidino-2-phenylindole (DAPI) was 263 
purchased from Invitrogen.  264 
 265 
Animal experiments. To evaluate the pathogenicity and host range restriction of SV-266 
A, 3-day-old piglets (n = 27) from sows by hysterectomy and 3-day-old SPF White 267 
Leghorn chicks (n = 27) were used. Twenty-four piglets and 24 chicks were orally 268 
inoculated with 20 ml (1 x 108 PFU/ml) or 5 ml (1 x 108 PFU/ml) of the KS04105 269 
strain individually. As negative controls, piglets and chicks were inoculated with the 270 
same volume of medium for mock-infection. All animals were fed with sterilized 271 
commercialized milk or feed. After the inoculation, clinical signs including diarrhea, 272 
pneumonia, and convulsion were evaluated daily as described previously (Park et al., 273 
2013). Animals were euthanized at specified times (Table 1).  274 
Necropsy was immediately performed after euthanasia. During necropsy, organs 275 
and tissues including each intestinal segment, spinal cords, brain, lung, and liver 276 
were excised from piglets or chicks. They were immediately placed in 10% buffered 277 
formalin for histological examination. Formalin-fixed samples were embedded in 278 
paraffin, sectioned, stained with Mayer’s hematoxylin and eosin, and examined 279 
microscopically (Park et al., 2013). All samples collected for qRT-PCR analysis were 280 
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immediately snap-frozen in liquid nitrogen and kept at -80℃ until use.  281 
 282 
Immunohistochemistry. The distribution of SV-A antigens in tissues was evaluated 283 
through immunohistochemical examination using paraffin-embedded sections and a 284 
Mab against SV-A capsid protein as described previously (Park et al., 2007). Briefly, 285 
paraffin-embedded sections of each organ and tissue were deparaffinized and 286 
rehydrated through a graded series of alcohol in 0.1 M PBS and then treated with 0.1% 287 
trypsin-0.1% calcium chloride in PBS for 1 hr at 37˚C. Trypsinized sections were first 288 
treated with 3% H2O2 to quench endogenous peroxidase and then incubated with a 289 
Mab against SV-A capsid protein at 4˚C overnight. All sections were stained with 290 
peroxidase-labelled streptavidin-biotin (SAB-PO) using a Histofine SAB-PO kit for 291 
the mouse Mab. Antigen localization was visualized by incubating the sections with 292 
3,3’-diamonobenzidine-H2O2 solution. The sections were then weakly counterstained 293 
with hematoxylin. To calculate the number of antigen-positive cells in the organs or 294 
tissues, 10 fields per section were analyzed, using a 40x objective and a 10x 295 
eyepiece, yielding a final magnification of 400x.  296 
 297 
Virus purification by CsCl gradient centrifugation. SV-A strain KS04105 grown in 298 
LLC-PK cells was purified using cesium chloride (CsCl) gradient centrifugation as 299 
described previously (Kim et al., 2016). Briefly, infected cell cultures were harvested 300 
at 72 hr post-inoculation and freeze-thawed three times. Cell debris was spun down 301 
at 2,469 x g for 10 min at 4℃. A total of 500 ml of virus-containing supernatants was 302 
concentrated by centrifugation at 245,853 x g for 20 hr at 4℃ using a SW40 rotor 303 
(Beckman). The viruses in the pellets were resuspended in TNE buffer (50 mM Tris-304 
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HCl, 100 mM NaCl, 100 mM EDTA, pH 7.5). The suspension was then layered over 305 
discontinuous CsCl gradients. After ultracentrifugation, the virus band was collected 306 
by puncturing the side of the tube with a needle. The virus solution was then diluted 307 
in distilled water and further purified by ultracentrifugation. Purified viruses were 308 
dialysed in 0.1 M sodium bicarbonate buffer (pH 8.3) for fluorescence labelling or in 309 
TNE buffer for radioactivity assay overnight. Purified viruses were then stored in 310 
aliquots at –80℃.  311 
 312 
Labelling of viruses with AF-594. Labelling of viruses with AF-594 was performed 313 
as described previously (Kim et al., 2016). Briefly, purified virus (10 mg at 1 mg ml-1) 314 
in 0.1 M sodium bicarbonate buffer (pH 8.3) was labelled with one tenth fold-molar 315 
concentration of AF-594 succinimidyl ester (1 mg at 1 mg ml-1 in DMSO). Each 316 
reaction was mixed thoroughly by vortexing for 30 sec and incubated at room 317 
temperature for 1 hr with continuous stirring. Labelled virus was repurified with CsCl 318 
as described above, dialysed against virion buffer, and stored in 2-µg aliquots at –319 
20℃.  320 
 321 
Dye-labelled binding assay. Dye-labelled binding assay was performed with 322 
purified AF-594 labelled-viruses as described previously (Kim et al., 2016). Briefly, 323 
mock-infected or treated cells were inoculated with multiplicity of infection (MOI) of 324 
1000 of AF-594 labelled-virus and incubated on ice for 5 min followed by incubation 325 
at room temperature for 10 min. Cells were washed extensively with cold PBS, fixed 326 
with 4% formaldehyde, and washed three times with cold PBS. Dishes were 327 
mounted with SlowFade Gold Antifade Reagent containing DAPI solution for nucleus 328 
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staining. Infected cells were observed under a LSM 510 confocal microscope and 329 
analysed using LSM software (Carl Zeiss). 330 
 331 
Labelling of viruses with 35[S]methionine/cysteine. Labelling of viruses with 332 
35[S]methionine/cysteine (PerkinElmer) was carried out as described previously (Kim 333 
et al., 2016). Briefly, confluent monolayers of cells were infected with SV-A strain 334 
KS04105 at a MOI of 0.1 PFU/cell at 37℃ for 4 hr. The medium was replaced with 335 
RPMI 1640 lacking methionine and cysteine (Sigma-Aldrich). After starving cell for 2 336 
hr, cells were supplemented with 1 Mbq 35[S]methionine/cysteine (PerkinElmer) ml-1. 337 
At 72 hr following virus infection, each labelled virus was purified by CsCl density-338 
gradient centrifugation as described above.  339 
 340 
Binding assay of 35[S]methionine/cysteine labelled virus to various cell lines. 341 
Binding of 35[S]methionine/cysteine labelled virus to various cell lines was assayed 342 
as described previously (Kim et al., 2016). Briefly, cells (4 x 104) were plated into 96-343 
well plates. Purified 35[S]methionine/cysteine-labelled virus (50,000 c.p.m.) was 344 
incubated with cells on ice for 45 min. Cells were washed three times with ice-cold 345 
PBS followed by cell lysis with 0.1% sodium dodecyl sulphate and 0.1 M NaOH. 346 
Total radioactivity in the cell lysate was determined by liquid scintillation counting.  347 
 348 
Infectivity assay. Infectivity assay of SV-A strain KS04105 in various cell lines was 349 
carried out as described previously (Kim et al., 2016). Briefly, confluent monolayers 350 
of each cell line on confocal dish were infected with SV-A strain KS04105 at a MOI 351 
of 1 PFU/cell and incubated at 37℃ for 1 hr. Cells were washed three times with 352 
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PBS and replaced with maintenance medium. Cells were incubated at 37℃ for 15 hr 353 
prior to being fixed with 4% formaldehyde in PBS. They were subjected to 354 
immunofluorescence assay as described below. 355 
 356 
Immunofluorescence assay. Immunofluorescence assay was performed as 357 
previously reported (Kim et al., 2016). Briefly, fixed cells on confocal dish were 358 
permeabilized by 0.2% Triton X-100, incubated at room temperature for 10 min, and 359 
washed with PBS containing 0.1% new born calf serum (PBS-NCS). Mab against 360 
SV-A capsid protein (1:40 dilution) was added and incubated at 4℃ overnight. Cells 361 
were then washed three times with PBS-NCS. FITC-conjugated secondary antibody 362 
(diluted to 1:100) was then added. Nuclei were stained with propidium iodide. Cells 363 
were then examined through confocal microscopy.  364 
 365 
SV-A qRT-PCR. SV-A genome RNA levels in the feces, sera and each organ or 366 
tissue were quantified by qRT-PCR as described previously with slight modifications 367 
(Chen et al., 2014; Park et al., 2013). Briefly, all tissues and fluid samples collected 368 
from experimental animals were individually weighed, homogenized or vortexed at a 369 
1:10 dilution in 0.01 M PBS and centrifuged (tissues 13,000 × g for 3 min; fecal 370 
samples 5,000 × g for 10 min).  The supernatants along with the remaining bulk 371 
samples were collected and stored at −80˚C for analysis. To quantitate SV-A genome 372 
copy numbers, cells were infected without or with SV-A strain KS04105 at a MOI of 1 373 
PFU/cell and incubated at 37℃ for 4, 8, 15, 72 hr post-infection as described above. 374 
Each infected cell culture was freeze-thawed three times, and cell debris was spun 375 
down at 2,469 x g for 10 min at 4℃. After extracting total RNA from supernatants, 376 
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each real time RT-PCR reaction was performed using a Rotor-Gene Real-Tme 377 
Amplification system (Corbett Research, Mortlake, Australia) and SensiFAST SYBR 378 
Low-ROX One-Step Mix (Enzynomics Inc, Korea) in a final volume of 20 µl 379 
containing 10 µl of SensiFAST SYBR Low-ROX One-Step Mix (Enzynomics Inc, 380 
Korea), 0.2 µl of reverse transcriptase, 0.4 µl of RiboSafe RNase Inhibitor, 0.8 µl of 381 
PSV1 primer (GGCAGTAGCGTGGCGAGC at positions between 153-170 of the 382 
5’UTR), 0.8 µl of PSV2 primer (CTACTCTCCTGTAACCAGT at positions between 383 
242-260 of the 5’UTR), 4 µl of template, and 3.8 µl RNase free dH2O. Reverse 384 
transcription was carried out at 42°C for 15 min followed by the activation of hot-start 385 
DNA polymerase at 95°C for 2 min and 45 cycles of 95°C for 10 sec, 60°C for 14 sec, 386 
and 72°C for 10 sec. Quantitation of virus RNA copies was carried out using a 387 
standard curve derived from 10-fold serial dilutions of in vitro transcripted 388 
complementary RNA (cRNA) amplified in separate PCR tubes. Rotorgene 6000® 389 
(Corbett Research) software was used to calculate the amount of SV-A specific RNA 390 
in the samples. The threshold was defined automatically in the initial exponential 391 
phase, reflecting the highest amplification rate. With regard to the crossing points 392 
resulting from the amplification curves and threshold, a direct relation between cycle 393 
number and log concentration of RNA molecules initially present in the RT-PCR 394 
reaction was evident. By linear regression analysis of these data, Rotorgene 6000® 395 
software was used to set up a standard curve to determine the concentration of RNA 396 
present in the samples. 397 
 398 
Ethics statement. All animals were handled in strict accordance with good animal 399 
practices as described in the NIH Guide for the Care and Use of Laboratory Animals 400 
(NIH Publication No. 85-23, 1985, revised 1996). Our experiment protocol was 401 
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approved by the Committee on Ethics of Animal Experiments, CNU with permit 402 
number of CNU No. 2012-87.  403 
 404 
Statistical analysis. All statistical analyses were performed using SPSS version 405 
11.5.1 for Windows (SPSS, USA). One-way analysis of variance (ANOVA) was used 406 
to determine the statistical significance (P < 0.05).  407 
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FIGURE LEGENDS 514 
Fig. 1. SV-A viral RNA levels in feces (a), serum (b), spinal cord (c), brain (d), and 515 
lung (e) samples obtained from SV-A-inoculated piglets and chicks were determined 516 
by SYBR Green real-time RT-PCR. All experiments were performed three 517 
independent times. Error bars indicated SD from triplicate experiments. Dashed line 518 
indicates the limit of detection.   519 
 520 
Fig. 2. Histological changes and antigen distribution in the intestine of piglets 521 
inoculated with or without SV-A. Small and large intestinal tissues collected from 522 
mock- or SV-A-inoculated piglets were examined histopathologically and 523 
immunohistochemically. Bars = 200 µm. Duo, Jej, Ile and Col are abbreviations of 524 
duodenum, jejunum and colon, respectively.  525 
 526 
Fig. 3. Histological changes and antigen distribution in extra-intestinal organs and 527 
tissues of piglets inoculated with or without SV-A. Lung, brain, and spinal cord 528 
sampled collected from mock- or SV-A-inoculated piglets were examined 529 
histopathologically and immunohistochemically. Panels c, g, k, and o represented 530 
higher magnifications of samples shown in panels b, f, j, and n, respectively. Bars = 531 
200 µm (a, b, d, e, f, h, i, j, l and p), 100 µm (m and n), or 50 µm (c, g, k and o).  532 
 533 
Fig. 4. Histological changes and antigen distribution in intestinal and extra-intestinal 534 
organs and tissues collected from chicks inoculated with or without SV-A. Intestinal, 535 
lung, brain, and spinal cords isolated from mock- or SV-A-inoculated chicks were 536 
examined histopathologically and immunohistochemically. Bars = 100 µm (a, b, d, e, 537 
g, h, j and k) or 50 µm (c, f, i and l). Duo is an abbreviation of duodenum. 538 
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 539 
Fig. 5. SV-A binds to and infects cells of porcine origin. (a) Binding of AF-594-540 
labelled mock or SV-A (50,000 c.p.m) to various cells from different species was 541 
observed by confocal microscopy. (b) Binding of 35[S]Methionine/Cysteine-labelled 542 
mock or SV-A (50,000 c.p.m) to various cells from different species was measured 543 
by liquid scintillation counting. (c) Infectivity of SV-A to various cells from different 544 
species was determined by immunofluorescence assay using a mouse monoclonal 545 
antibody against SV-A VP1 protein at 15 hr post infection. (d) Quantification of SV-A 546 
genome copy numbers in various cells from different species was determined by 547 
SYBR Green real-time RT-PCR. All experiments were performed three independent 548 
times. Error bars indicated SD from triplicate experiments. Dashed line indicates the 549 
limit of detection. 550 
